Pfizer Ltd.

4590.00 +208.65 ▲4.8%

28 February 2024, 04:01:00 PM
Volume: 1,060

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pfizerltd.co.in
Market Cap 20,998.21 Cr.
Enterprise Value(EV) 18,154.02 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 109.76 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 41.82 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 743.86 Trailing Twelve Months Ending 2023-12
Price to Book Value 6.17 Calculated using Price: 4,590.00
Dividend Yield 1.53 Period Ending 2023-03
No. of Shares Subscribed 4.57 Cr. 45,747,732 Shares
FaceValue 10
About Pfizer Ltd.
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.

Pfizer Ltd. Delivery

Delivered Qty
Traded Qty

Pfizer Ltd. Performance

1 Day
+4.76%
1 Week
-0.36%
1 Month
+7.09%
3 Month
+12.82%
6 Month
+19.34%
1 Year
+20.68%
2 Year
+5.43%
5 Year
+46.98%
10 Year
+302.91%

Pfizer Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 7.63 14.75 14.7 14.11 15.07 15.89 17.19 23.3 20.55
Return on Capital Employed (%) 18.19 22.78 22.62 21.49 23.22 20.38 23.62 29.78 27.56
Return on Assets (%) 5.75 11.22 10.95 10.36 11.25 12.2 13 17.24 16.09

Pfizer Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1,973 2,164 2,419 2,683 3,011 3,395 2,393 2,864 3,207 3,273
Non Curr. Liab. -35 66 62 52 37 136 85 136 38 24
Curr. Liab. 609 658 780 954 892 873 774 853 657 614
Minority Int.
Equity & Liab. 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,903 3,911
Non Curr. Assets 1,295 1,256 1,210 1,273 1,225 1,357 1,344 1,457 1,378 1,362
Curr. Assets 1,252 1,614 2,033 2,403 2,702 3,013 1,873 2,361 2,493 2,549
Misc. Exp. not W/O
Total Assets 2,547 2,888 3,261 3,690 3,940 4,405 3,252 3,854 3,903 3,911

Pfizer Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,853 2,012 1,966 1,969 2,082 2,152 2,239 2,611 2,425 2,219
Other Income 72 87 101 114 167 184 81 63 101 137
Total Income 1,925 2,099 2,067 2,083 2,249 2,336 2,320 2,674 2,526 2,356
Total Expenditure -1,474 -1,579 -1,616 -1,468 -1,516 -1,579 -1,526 -1,775 -1,616 -1,591
PBIDT 451 520 451 615 733 757 794 899 910 765
Interest -2 -1 -2 -1 -2 -11 -15 -11 -13 -11
Depreciation -131 -58 -63 -66 -71 -103 -109 -115 -106 -75
Taxation -138 -165 -180 -188 -231 -133 -171 -160 -200 -165
Exceptional Items -80 10 130 33 -12
PAT 100 305 337 360 429 509 498 613 624 502
Adjusted EPS 22 67 74 79 94 111 109 134 136 110

Pfizer Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 132 113 345 329 332 98 323 427 667 356
Cash Fr. Inv. 103 -89 -701 -250 -238 35 1,530 -469 -575 -36
Cash Fr. Finan. -1,360 -1 -62 -83 -110 -110 -164 -1,571 -181 -346
Net Change -1,125 23 -417 -3 -17 23 1,690 -1,613 -88 -26
Cash & Cash Eqvt 308 488 71 68 51 74 1,764 151 63 37

Pfizer Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92 63.92
Public 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08 36.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Pfizer Ltd. Announcements

Fri, 23 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of shares certificates and issue of Letter of Confirmation
Wed, 21 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificates and issue of Letter of Confirmation
Fri, 09 Feb 2024
Board Meeting Outcome for Re-Appointment Of Ms. Meena Ganesh As An Independent Director.
Re-appointment of Ms. Meena Ganesh

Pfizer Ltd. Technical Scans

Tue, 27 Feb 2024
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Week Low Close Below Last Week Low
Closing Below Previous Low for 2 Days Closing Below Previous Low for 2 Days

Pfizer Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 379,622.78 1,570.50 -0.7%
Cipla Ltd. 120,180.38 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,577.80 6,420.70 -0.4%
Zydus Lifesciences Ltd. 95,400.24 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. 95,163.88 6,371.85 -3.7%
Divi's Laboratories Ltd. 93,921.46 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. 88,823.31 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.62 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.41 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.58 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 120.56 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 67.91 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.45 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.08 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.64 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.09 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.21 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.42 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

Pfizer Ltd. FAQ's

What is Pfizer share price?

Can I buy Pfizer shares now?

What is the Dividend Yield of Pfizer?

What is the Market Cap of Pfizer?

What are the key metrics to analyse Pfizer?

What is the 52 Week High and Low of Pfizer?

What is the trend of Pfizer share price?